Iron Metabolism in Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 230
Special Issue Editors
Interests: iron; macrophages; tumor; liver; cholangiocarcinoma
Special Issues, Collections and Topics in MDPI journals
Interests: liver tumors; iron metabolism; tumor microenvironment; iron homeostasis; cholangiocarcinoma; macrophages; erythropoiesis
Special Issue Information
Dear Colleagues,
It has been shown that tumor cells display unique metabolic and bioenergetic features, including deregulation in iron metabolism. Several studies have shown that the reprogramming of iron metabolism is a key function for a cancer cell and that the disruption of iron homeostasis may play an important role in cancer development and progression. This Special Issue will provide insights into changes occurring in iron metabolism during carcinogenesis, with a particular focus on the influence of the microenvironment on it. In fact, an increasing number of studies support the role of the surrounding tumor microenvironment in regulating tumor cell metabolic plasticity. Moreover, a general metabolic rewiring can be observed in cancer cells upon the reprogramming of iron metabolism, favoring tumor development, survival, and metastasis development. Hence, the Special Issue will also aim to explore how dysregulation in iron metabolism may influence the other metabolic pathways in tumor cells, highlighting the importance of targeting iron metabolism as a novel therapeutic strategy for tumors.
Dr. Margherita Correnti
Dr. Stefania Recalcati
Dr. Elena Gammella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- iron metabolism
- cancer
- microenvironment
- tumor metabolism
- metabolic rewiring
- tumor plasticity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
